# Evaluation of Effectiveness and Safety of Bioresorbable Vascular Scaffold in Routine Clinical Practice

> **NCT02622100** · — · TERMINATED · sponsor: **Duk-Woo Park, MD** · enrollment: 629 (actual)

## Conditions studied

- Arterial Occlusive Diseases
- Cardiovascular Diseases
- Coronary Artery Disease
- Coronary Disease

## Interventions

- **DEVICE:** Bioresorbable Vascular Scaffold

## Key facts

- **NCT ID:** NCT02622100
- **Lead sponsor:** Duk-Woo Park, MD
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2016-02-26
- **Primary completion:** 2019-03-23
- **Final completion:** 2023-12
- **Target enrollment:** 629 (ACTUAL)
- **Why stopped:** Due to stop BVS supply discontinuation
- **Last updated:** 2023-12-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02622100

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02622100, "Evaluation of Effectiveness and Safety of Bioresorbable Vascular Scaffold in Routine Clinical Practice". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02622100. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*